Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pertuzumab market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pertuzumabmarket, defines the market attractiveness level of Pertuzumab market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pertuzumab industry, describes the types of Pertuzumab market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pertuzumab market and the development prospects and opportunities of Pertuzumab industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pertuzumab market in Chapter 13.
By Player:
Novartis AG
Bio-Techne
InvivoGen
Celltrion
Pfizer
Biocon Limited
Abnova Corporation
By Type:
Human Source
Animal Source
By End-User:
Hospital
Medical Center
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pertuzumab Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pertuzumab Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pertuzumab Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pertuzumab Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pertuzumab Market Analysis and Outlook to 2022
-
7.1 Global Pertuzumab Consumption (2017-2022)
-
7.2 United States Pertuzumab Consumption (2017-2022)
-
7.3 Europe Pertuzumab Consumption (2017-2022)
-
7.4 China Pertuzumab Consumption (2017-2022)
-
7.5 Japan Pertuzumab Consumption (2017-2022)
-
7.6 India Pertuzumab Consumption (2017-2022)
-
7.7 South Korea Pertuzumab Consumption (2017-2022)
8 Region and Country-wise Pertuzumab Market Analysis and Outlook to 2028
-
8.1 Global Pertuzumab Consumption Forecast (2022-2028)
-
8.2 United States Pertuzumab Consumption Forecast (2022-2028)
-
8.3 Europe Pertuzumab Consumption Forecast (2022-2028)
-
8.4 China Pertuzumab Consumption Forecast (2022-2028)
-
8.5 Japan Pertuzumab Consumption Forecast (2022-2028)
-
8.6 India Pertuzumab Consumption Forecast (2022-2028)
-
8.7 South Korea Pertuzumab Consumption Forecast (2022-2028)
9 Global Pertuzumab Market Outlook by Types and Applications to 2022
-
9.1 Global Pertuzumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Human Source Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Animal Source Consumption and Growth Rate (2017-2022)
-
9.2 Global Pertuzumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Medical Center Consumption and Growth Rate (2017-2022)
10 Global Pertuzumab Market Outlook by Types and Applications to 2028
-
10.1 Global Pertuzumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Human Source Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Animal Source Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pertuzumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Medical Center Consumption Forecast and Growth Rate (2022-2028)
11 Global Pertuzumab Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pertuzumab Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pertuzumab Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pertuzumab Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pertuzumab Market Competitive Analysis
-
14.1 Novartis AG
-
14.1.1 Novartis AG Company Details
-
14.1.2 Novartis AG Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis AG Pertuzumab Product and Service
-
14.2 Bio-Techne
-
14.2.1 Bio-Techne Company Details
-
14.2.2 Bio-Techne Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bio-Techne Pertuzumab Product and Service
-
14.3 InvivoGen
-
14.3.1 InvivoGen Company Details
-
14.3.2 InvivoGen Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 InvivoGen Pertuzumab Product and Service
-
14.4 Celltrion
-
14.4.1 Celltrion Company Details
-
14.4.2 Celltrion Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Celltrion Pertuzumab Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Pertuzumab Product and Service
-
14.6 Biocon Limited
-
14.6.1 Biocon Limited Company Details
-
14.6.2 Biocon Limited Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Biocon Limited Pertuzumab Product and Service
-
14.7 Abnova Corporation
-
14.7.1 Abnova Corporation Company Details
-
14.7.2 Abnova Corporation Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Abnova Corporation Pertuzumab Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pertuzumab
-
Figure Pertuzumab Picture
-
Table Global Pertuzumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pertuzumab Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pertuzumab Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pertuzumab Consumption by Country (2017-2022)
-
Figure United States Pertuzumab Consumption and Growth Rate (2017-2022)
-
Table Europe Pertuzumab Consumption and Growth Rate (2017-2022)
-
Figure China Pertuzumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Pertuzumab Consumption and Growth Rate (2017-2022)
-
Figure India Pertuzumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pertuzumab Consumption and Growth Rate (2017-2022)
-
Figure Global Pertuzumab Consumption Forecast by Country (2022-2028)
-
Figure United States Pertuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pertuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pertuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pertuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pertuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pertuzumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human Source Consumption and Growth Rate (2017-2022)
-
Figure Global Animal Source Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Center Consumption and Growth Rate (2017-2022)
-
Figure Global Human Source Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Animal Source Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Center Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pertuzumab Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pertuzumab Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Pertuzumab Product and Service
-
Table Bio-Techne (Foundation Year, Company Profile and etc.)
-
Table Bio-Techne Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Techne Pertuzumab Product and Service
-
Table InvivoGen (Foundation Year, Company Profile and etc.)
-
Table InvivoGen Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table InvivoGen Pertuzumab Product and Service
-
Table Celltrion (Foundation Year, Company Profile and etc.)
-
Table Celltrion Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celltrion Pertuzumab Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Pertuzumab Product and Service
-
Table Biocon Limited (Foundation Year, Company Profile and etc.)
-
Table Biocon Limited Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocon Limited Pertuzumab Product and Service
-
Table Abnova Corporation (Foundation Year, Company Profile and etc.)
-
Table Abnova Corporation Pertuzumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abnova Corporation Pertuzumab Product and Service
-
